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Sllnullary 
We have identified a serine/threonine kinase that is rapidly activated during Fas-mediated apop- 
tosis. Fas-activated serine/threonine kinase (FAST) is phosphorylated  on serine and threonine 
residues in Jurkat cells. In response to Fas ligation, it is rapidly dephosphorylated and concomi- 
tantly activated to phosphorylate TIA-1, a nuclear RNA-binding protein that has been impli- 
cated as an effector of apoptosis. Phosphorylation of TIA-1 precedes the onset of DNA fragmen- 
tation,  suggesting a role in signaling downstream events in the apoptotic program.  Our results 
introduce FAST and TIA-1 as components of a molecular cascade  involved  in signaling Fas-mediated 
apoptosis. 
Poptotic  cell death is required  for  the normal devel- 
opment and survival of multicellular organisms (1, 2). 
Just as cells induced to proliferate activate a programmed se- 
ries of biochemical events leading to cell division (i.e., mi- 
tosis), cells induced to die activate a distinct program of bio- 
chemical events leading to cell death (i.e., apoptosis). Whereas 
the morphological changes accompanying both mitosis (3) 
and apoptosis (4) have been appreciated for many years, the 
biochemical events underlying these changes are only begin- 
ning to be understood.  In the case of mitosis, genetic anal- 
ysis of cell division cycle mutants in yeast has shown that 
the molecular effectors of cell division are a family of highly 
regulated cyclin-dependent  kinases (5). Although some cyclin- 
dependent kinases are also activated during apoptosis (6, 7), 
specific molecular effectors of apoptosis have not yet been 
identified. 
One of the most potent triggers of lymphocyte apoptosis 
is the Fas antigen, a tumor necrosis factor receptor-related 
cell surface molecule (8), whose expression is induced by lym- 
phocyte activation (9,  10). Ligation of Fas antigen, either 
by Fas ligand or by specific mAbs, rapidly induces apoptosis 
in susceptible  lymphocytes.  Although the activation of a sphin- 
gomyelinase  to produce ceramide may be involved  in signaling 
Fas-mediated apoptosis (11), ceramide production also occurs 
in response to cytokines that do not trigger apoptosis (12, 
13), indicating that additional effector molecules specific  for 
apoptosis might be activated by ceramides. The ability of 
ceramides to activate selected  protein kinases (14, 15) and phos- 
phatases (16) suggests that these lipid mediators might regu- 
late the phosphorylation of specific apoptotic effector mol- 
e~.lles. 
We have identified a family of RNA recognition motif 
(RRM)l-type  RNA-binding proteins  that  are  candidate 
effectors of apoptotic cell death.  The first member of this 
family was identified using an mAb reactive with a 15-kD 
cytotoxic granule-associated protein (p15-TIA-1), the expres- 
sion of which is restricted to cytotoxic lymphocytes (17-21). 
This antibody also recognizes two related RRM-type RNA- 
binding proteins designated p40-TIA-1 and p53-TIA-1 (based 
on their apparent molecular weights of 40,000 and 53,000) 
which are expressed in a variety of cell types (17, 22). Im- 
munochemical analysis indicates that p15-TIA-1 is structur- 
ally related to the carboxyl terminus of p40-TIA-1 which en- 
codes a glutamine-rich protein interaction domain (22). The 
ability of both p15-TIA-1 and p40-TIA-1 to trigger DNA frag- 
mentation in permeabilized thymocytes has implicated these 
molecules as candidate effectors of CTIrmediated apoptosis 
(22). Although the molecular mechanism whereby the pro- 
tein interaction domain of an RNA-binding protein might 
trigger apoptosis is unknown, we have proposed that p15- 
TIA-1 might affect the function of p40-TIA-1 in target cells 
by interacting with a common protein (22, 23). We there- 
fore used the two-hybrid system to screen for proteins capable 
of interacting with the carboxyl terminus of p40-TIA-1. Here 
i Abbreviations  used in this paper'. FAST, Fas-activated serine/threonine ki- 
nase;  GST, glutathione-S-transferase; HA-FAST,  hemagglutinin-tagged 
FAST; PVDF, polyvinylidene  difluoride; RRM, RNA recognition motif. 
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nine kinase (FAST), a 60-kD serine/threonine kinase that binds 
to the carboxyl terminus of p40-TIA-1. FAST is a constitu- 
tively phosphorylated protein that is rapidly dephosphory- 
lated after Fas ligation. Dephosphorylated FAST is activated 
to phosphorylate p40-TIA-1 before the onset of DNA frag- 
mentation. Our results suggest that FAST activation may 
be involved in triggering downstream events in the apop- 
totic program. 
Materials and Methods 
Identification  of TIA-l-binding  Proteins 
The eDNA encoding p40-TIA-1 was cloned into the multilinker 
of the pMA424 vector to produce a fusion protein consisting of 
the GAL4 DNA-binding domain (1-147) at the amino terminus 
and p40-TIA-1 at the carboxyl terminus. Transformation of yeast 
strain GGY1::171 with this recombinant plasmid followed by se- 
lection on synthetic culture-histidine plates resulted in the efficient 
expression of the fusion protein (data not shown). Because this 
fusion protein lacks the GAL4 activation domain, it was unable 
to induce ~-galactosidase  expression which in GGYl::171 is under 
control of the GAL4 promoter. The identification of cDNAs en- 
coding TIA-l-binding proteins was then accomplished  by cotrans- 
forming GGYl::171 cells with pMA424(TIA-1) and a cDNA li- 
brary (B cell eDNA was cloned into the XhoI site of pSE1107) 
expressing fusion proteins consisting of the GAL4 activation do- 
main (768-881) at the amino terminus and peptides encoded by 
individual cDNAs at the carboxyl terminus. Selection for double 
transformants  expressing ~-galactosidase  (i~e., blue colonies  on X-gal 
plates) identifies cDNAs encoding candidate TIA-l-binding pro- 
teins which juxtapose the GAL4 activation domain and the GAL4 
DNA-binding domain as a consequence  of the TIA-1.'TIA-1  binding 
protein interaction. From 1 x  106 double transformants screened, 
we identified four B-galactosidase-expressing  transformants. The 
recombinant pSE1107 plasmid  from one of these transformants  con- 
tained a 1.5-kb insert which was used as a probe to isolate a 1.8-kb 
full-length eDNA. Dideoxy sequencing  using Sequenase  (U.S. Bio- 
chemical Corp., Cleveland, OH) was performed using oligonucle- 
otide primers and alkaliIdenatured plasmid DNA as described by 
the suppliers. 
Construction of Fusion Proteins.  The eDNA encoding FAST was 
cloned into the EcolLI site of the polylinker region of pGEX-3X 
using oligonucleotide linkers. These constructs were designed to 
express FAST as a fusion protein with glutathione-S-transferase 
(GST). Individual fusion proteins were expressed in Escherichia coli 
(DHS),  and purified from  bacterial lysates using  glutathione- 
Sepharose (Sigma Chemical Co., St. Louis, MO). The purified fu- 
sion proteins were analyzed on a 10% SDS polyacrylamide  gel by 
staining with Coomassie blue. Fusion proteins were also analyzed 
by immunoblotting using rabbit polyclonal antisera raised against 
recombinant FAST. 
The  hemagglutinin-tagged  fusion protein  was  produced by 
cloning the eDNA-encoding FAST into the EcoRI site of pMT2- 
HA vector (provided by Dr. Michel Streuli, Dana-Farber Cancer 
Institute, Boston, MA). This recombinant plasmid was used to 
transfect COS calls in the transient assay described below. 
COS Cell Transfections.  COS ceils were transfected with the 
pMT-2 plasmid containing the indicated insert DNA using the 
diethylaminoethyl dextran method as described (24). After 48 h 
of culture, transfected ceUs were solubilized with lysis buffer, and 
used in the immunoprecipitation  and immunoblotting experiments 
described. 
866 
Immunoblot Analysis.  Immunoblotting analysis  was carried out 
as previously described (17). Immunoblots were developed using 
polyclonal  or monoclonal antibodies reactive with FAST, followed 
by horseradish peroxidase-conjugated protein A/G. Blots were re- 
vealed using the enhanced chemiluminescence detection system 
(Renaissance; DuPont  NEN Research Products, Boston, MA). 
Phosphoamino Acid  Analysis.  3~p-labeled immunoprecipitates 
were separated on a 10% SDS polyacrylamide  gel, transferred to 
polyvinylidene  difluoride (PVDF) (Immobilon P; Millipore Corp., 
Bedford, MA), and visualized by autoradiography. The indicated 
bands were excised and digested with 5.7 M HC1 at 110~  for 
1 h before drying in a speed vac. Hydrolysates were then lyophi- 
lized and separated using two-dimensional electrophoresis/TLC as 
described (25). 
Kinase Assays.  For in vitro kinase assays, individual immuno- 
precipitates were washed three times with 1% digitonin lysis  buffer, 
then once with TBS (150 mM NaC1, 20 mM Tris, pH 7.5) before 
resuspending in 30/~1 of kinase buffer (20 mM Tris, pH 7.5, 10 
mM MgC12, 2 mM MnC12, 20/~Ci [y-3zp]ATP [Dupont NEN; 
3,000 mCi/mmol]) for 20 min at 30~  The reaction was termi- 
nated by the addition of SDS sample buffer. Proteins were sepa- 
rated on a 12% SDS polyacrylamide  gel, and dried before autoradi- 
ographic exposure. 
For renaturation kinase assays, immunoprecipitates were sepa- 
rated  on  a  10%  SDS  polyacrylamide gel  and  transferred  to 
0.45-/~m PVDF before incubating in 7 M guanidine, 50 mM Tris, 
50 mM DTT, 2 mM EDTA, pH 8.3, for 1 h at room temperature. 
Immobilized proteins were then renatured by incubating in 100 
mM NaC1, 50 mM Tris, 2 mM DTT, 2 mM EDTA, 1% BSA (Sigma 
Chemical Co., St. Louis, MO), 0.1% (wt/vol) NP-40, pH 7.5, 
for 12-18 h at 4~  PVDF membranes were then incubated in 30 
mM Tris, 10 mM MgClz, 2 mM MnC12, pH 7.5, 30/~Ci [3'- 
3~p]ATP (3,000-6,000 Ci/mmol; New England Nuclear, Boston, 
MA) for 30 rain at room temperature, with gentle shaking. The 
kinase reaction was terminated by washing the membrane twice 
with 30 mM 'Iris, pH 7.5, and once with 1 M KOH for 5-10 rain, 
before rinsing with water before autoradiographic exposure (26). 
3zP-labeling  and  Cellular Activation.  Jurkat  cells  (2  x  106 
cells/ml) were incubated in phosphate-free RPMI (GIBCO BRL, 
Gaitherburg, MD) containing 5% dialyzed FCS and 0.2 mCi/ml 
32PO4 for 3-4 h at 37~  After the addition of activating mAbs, 
cells were centrifuged at the indicated times and lysed in either 
digitonin lysis  buffer (1% digitonin, 0.12% Triton-X 100, 150 mM 
NaC1, 1 mM EDTA, 20 mM triethanolamine, pH 7.8) or NP-40 
lysis  buffer (1% NP-40, 150 mM NaCI, 1 mM EDTA, 50 mM Tris, 
pH 7.8) containing freshly added protease inhibitors (1 mM PMSF, 
10/~g/ml leupeptin, 10 #g/ml aprotinin, 20 mM iodoacetamide). 
Immunoprecipitations using the indicated antibodies were per- 
formed as previously described (22). 
DNA Fragmentation.  Jurkat cells were treated with anti-Fas 
(7c11, IgM) for the indicated times, collected by centrifugation, 
and lysed in 20 mM Tris (pH 7.4), 0.4 mM EDTA, 0.4% Triton 
X-100. Solubilized  cells  were centrifuged at 14,000 rpm for 5 min. 
Supernatants were collected and adjusted to contain 0.5 M NaC1 
and an equal volume of isopropanol. After incubating overnight 
at  -70~  samples were thawed and centrifuged at 14,000 rpm 
for 10 min, washed once with 70% ethanol, and dried in a Speed- 
Vac (Savant, Farmingdale, NY). Pellets were resuspended in 20/~1 
of  Tris-EDTA buffer containing 0.1 mg/ml RNAase and incubated 
at 37~  for 30 min. After the addition of loading buffer, samples 
were separated on agarose gels (0.8%) and visualized under UV 
light. 
Antibodies.  mAbs  reactive with FAST were prepared by im- 
munizing a Balb/c mouse with affinity-purified  GST-FAST (100 
Fas-activated Serine/Threonine  Kinase mg was administered  intraperioneally  at 3-wk intervals for a total 
of four injections) in adjuvant before fusing immune splenocytes 
with the NS-1 hybridoma  partner as previously  described  (17). In- 
dividual hybridomas  were screened  for production of antibodies 
reactive with FAST using a solid-phase ELISA as previously  de- 
scribed (22). The isotype  of the mAbs  designated  anti-2B5 and anti- 
2D5 are both IgG2a. Anti-2B5 was found  to preferentially  recog- 
nize recombinant FAST expressed  in COS cells and was used to 
immunoprecipitate  this protein for in vitro kinase  assays. Anti-2D5 
was found to preferentially  recognize  endogenous  FAST, and was 
used to immunoprecipitate  FAST from Jurkat cells. 
Polyclonal  antibodies reactive  with FAST were prepared  by im- 
munizing rabbits with purified GST-FAST one time in CFA and 
subsequent times in incomplete Freund's adjuvant. Immune sera 
were depleted of antibodies reactive  with GST using a Sepharose- 
GST column. Preimmune sera were used in control experiments 
using these antisera. 
The production of mAbs reactive  with TIA-1 and TIAR were 
described previously  (22, 23), with the exception of ML29. This 
antibody was  produced using recombinant p40-TIA-1 as  im- 
munogen. The isotype of ML29 is IgG1. 
Results 
Identification of  a cDNA Encoding  FAST.  We used a genetic 
screen in yeast (i.e., the two-hybrid system [27, 28]) to iden- 
tify proteins capable of  interacting with the carboxyl terminus 
of p40-TIA-1 (22). The deduced amino acid sequence of one 
such protein (designated FAST, calculated molecular weight 
of 62,900) which interacted strongly with TIA-1, but only 
weakly with the related RNA-binding protein TIAR (23), 
is shown in Fig. 1 A. Comparison of this amino acid sequence 
with proteins in the EMBL data library identified a region 
that was similar (23%  identity over 240 amino acids using 
the FASTA algorithm, 12% identity over the 432 amino acid 
kinase domain using the alignment shown in Fig.  1 A) to 
a protein kinase domain encoded by the ICP10 gene of herpes 
simplex virus (29). Alignment of the amino acid sequence 
of FAST (amino acids 65-494)  with the protein kinase do- 
mains of ICP10 and cAPK-ol, reveals the presence of several 
of the "invariant residues" defined by protein kinase consensus 
motifs I-X (30) (bold type, Fig. 1 B). Both FAST and ICP10 
also encode proline-rich, putative SH3-binding domains (un- 
derlined in the FAST sequence shown in Fig. 1 B; the ICP10 
SH3-binding domain is encoded in the insert designated A 
in Fig. 1 B [29]). A single 1.8-kb FAST mRNA was found 
to be expressed in heart, brain, placenta, lung, liver, skeletal 
muscle, kidney, and pancreas by Northern analysis (data not 
shown). 
Analysis of Recombinant and Endogenous FAST.  Recom- 
binant FAST possesses intrinsic protein kinase activity as shown 
in Fig. 2. In this experiment, lysates from COS transformants 
expressing a recombinant FAST fusion protein containing an 
NH2-terminal hemagglutinin tag (HA-FAST) were immu- 
noprecipitated  using mAbs reactive with the HA tag (anti- 
HA), FAST (anti-2B5, an IgG2a mAb produced as described 
in Materials and Methods), or an isotype-matched control 
antibody, and immunoprecipitated proteins were incubated 
in kinase buffer containing ["/-32p]ATP (31). Fig. 2 A shows 
that precipitates prepared using anti-HA and anti-FAST, but 
not control mAb, include 65- and 60-kD phosphoproteins. 
The 65-kD phosphoprotein comigrates with recombinant HA- 
FAST in immunoblots (arrow, data not shown). The 65-kD 
phosphoprotein is also autophosphorylated  in the renatura- 
tion kinase assay (Fig. 2 B, arrow). In this assay, dectropho- 
retically separated proteins  are transferred to PVDF filters, 
renatured, and incubated in the presence of [3~-32p]ATP (32). 
This result confirms that the 65-kD protein has intrinsic ki- 
nase activity. The origin of the 60-kD phosphoprotein iden- 
tified in the in vitro kinase assay (Fig. 2 A) is not known, 
but it may be a degradation product derived from HA-FAST 
since it appears to be recognized by the anti-HA antibody. 
Phospho-amino acid analysis of the autophosphorylated ki- 
nase indicates that it is serine/threonine specific (Fig. 2 C). 
An mAb reactive with recombinant FAST (anti-2D5) im- 
munoprecipitates  a 60-kD phosphoprotein from 32p-labeled 
Jurkat cells (Fig. 3 A). In some experiments,  two isoforms 
of endogenous FAST (centered at 60 kD) can be resolved after 
separation on SDS-polyacrylamide gels (arrows). Like the au- 
tophosphorylated recombinant protein, endogenous FAST 
is phosphorylated exclusively  on serine and threonine residues 
(Fig. 3 B). 
Interaction between TIA-1 and FAST.  We used GST fusion 
proteins containing the carboxyl terminus of TIA-1 to dem- 
onstrate the intrinsic affinity between TIA-1 and FAST. Fig. 
4 A shows that NP-40 lysates  prepared from COS (HA-FAST) 
transformants  (as well as immunoprecipitates  prepared from 
these lysates using anti-FAST) contain a 65-kD protein that 
is recognized in immunoblots probed with an anti-FAST  mAb. 
Affinity precipitates prepared from these same lysates using 
immobilized GST-p15-TIA-1 or GST-p40-TIA-1, but not GST 
alone, also include FAST (arrow; the 46-kD protein seen in 
the GST-p15-TIA-1 lane is the GST fusion protein itself, which 
is nonspecifically  visualized in this assay). Because FAST con- 
tains a proline-rich domain (PPKPPPPLQP) that may interact 
with SH3 domains  (33), we also analyzed affinity precipi- 
tates prepared using immobilized GST fusion proteins con- 
taining the SH3 domain of the fyn tyrosine kinase. In data 
not shown, FAST was found to bind to fyn-SH3, but not 
fyn-SH2, indicating that FAST, like ICP10, can interact with 
proteins  possessing SH3 domains. 
The association between endogenous FAST and TIA-1 in 
mammalian cells was demonstrated in the coimmunoprecipi- 
tation experiments shown in Fig. 4 ~  Jurkat cells metaboli- 
caUy labeled with either 32p04 or [3SS]methionine  were solu- 
bilized in digitonin lysis buffer (the FAS'I2TIA-1 association 
was preserved in the presence of digitonin, but less efficiently 
in the presence of harsher detergents such as NP-40) and im- 
munoprecipitated using mAbs reactive  with either FAST (anti- 
2D5), TIA-1, or TIAR (anti-Ill10 preferentially recognizes 
TIA-1, whereas anti-6E3 and anti-3E6 preferentially recog- 
nize TIAR  [34]). mAbs reactive with TIA-1  and TIAR 
precipitate the 40-kD and 53-kD isoforms of their target RNA- 
binding  proteins  which are labeled  with  [35S]methionine 
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MRRPRGEPGP  RAPRPTEGAT  CAGPGESWSP  SPNSMLRVLL  SAQTSPARLS  50 
GLLLIPPVQP  CCLGPSKWGD  RPVGGGPSAG  PVQGLQRLLE  QAKSPGELLR  100 
WLGQNPSKVR  AHHYSVALRR  LGQLLGSRPR  PPPVEQVTLQ  DLSQLIIRNC  150 
PSFDIHTIHV  CLHLAVLLGF  PSDGPLVCAL  EQERRLRLPP  KPPPPLQPLL  200 
RGGQGLEAAL  SCPRFLRYPR  QHLISSLAEA  RPEELTPHVM  VLLAQHLARH  250 
RLREPQLLEA  IAHFLVVQET  QLSSKVVQKL  VLPFGRLNYL  PLEQQFMPCL  300 
ERILAREAGV  APLATVNILM  SLCQLRCLPF  RALHFVFSPG  FINYISGTPH  350 
ALIVRRYLSL  LDTAVELELP  GYRGPRLPRR  QQVPIFPQPL  ITDRARCKYS  400 
HKDIVAEGLR  QLLGEEKYRQ  DLTVPPGYCT  DFLLCASSSG  AVLPVRTQDP  450 
FLPYPPRSCP  QGQAASSATT  RDPAQRVVLV  LRERWHFCRD  GRVLLGSSRA  500 
LRERHLGLMG  YQLLPLPFEE  LESQRGLPQL  KSYLRQKLQA  LGLRWGPEGG  550 
FAST  (64) 
A  B 
P  SKWGDRPVGC4~P  SAGPVQGLQRLLEQAKSPGELLRWLGQNP  SKVRAHHYSVALRRLGQLLGSRPRPPPV  (  134  ) 
ICP-10  (60)  VAISNVAAGGDGRT--AVVALGGTSG  .... (50)---ARGC4&F.J~)VGAAESWSDG  PSSDS 
cAPK-~  (40)  DQFERIKTLGTGSF-GRVMLVKHME  ........... TGNHYR/~KILDKQKVVKLK  .QIEHTLN - 
Consensus:  G  G  G  V  A  K 
I  II 
*  **  *  *  *  * 
FAST  EQVTLQDLSQLIIRNCPSFDIHTIHVCLHLAVLLGFPSDGPLVCALEQERRLRL  .......  PPKPPPPLQ(197) 
ICP-10  ETEDSDSSDEDTGSGSETLSRSSSIWAAGATDDDDSDSDSRSDDSVQPDVVVRRRWSDGPAPVAFPKPRR 
cAPK-U  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY  .... 
Consensus:  _~ 
IXI  IV 
C 
FAST  PLLRGGQGLEAALSCPRFLRYPRQHLI  ...............  SSLAEARPEELTPHVMVL(242) 
ICP-10  PGDSPGNPGLGAGTGPGSATDPRASADSDSAAHAAAPQADVAPVLDSQPTVGTDPGYPVPLELTPENAEA 
cAPK-~  ...............................  :  .................... LHSLDLIYRDLKPENLLI 
Consensus: 
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D 
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DQQGY  ....................................  IQVIDFGFAKRVKGRIWILCGTP  ....... 
FAST 
ICP-10 
CAPK-a 
Consensus:  DIG 
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E 
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ICP  -  10  AYTP  .................................................  YHLREYATRLVNGFKPL 
cAPK-a  ....................................................  EYLAPEI 
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F 
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FAST  DPFLPYPPRSCPQGQAAS SATTRDPAQRVVLVLRERWHFCRDGRVL  (  496  ) 
ICP-  10  NTLVERGLQS ALKYEEHYLKRHGGHYME SVHQMYTRIAGP LACRAT 
cAPK-~  ........................  FS  SDLKDLLRNLLQVDLTKRFG 
Consensus :  L  R 
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Figure 1.  (A) Deduced amino acid sequence of FAST. (13) Comparison of the kinase domains encoded by FAST, the HSV serine/threonine kinase 
ICPl0, and the catalytic subunit of cAMP-dependent protein kinase (cAPK-a). Amino acid identity between FAST and ICPl0 is indicated by asterisks. 
Residues conforming to the consensus kinase motifs (designated by roman numerals) are shown in bold type. Catalytic domain inserts identified by 
comparison with cAPK-a are overlined and labeled A-G. The proline-rich, putative SH3 domain-binding  site is underlined. The EMBL database acces- 
sion number for this  nucleotide sequence is X86779. 
868  Fas-activated Serine/Threonine Kinase Figure 2.  HA-FAST is a setine/threonine kinase.  (A) In vitro kinase 
assay performed using immunoprecipitates prepared from Cos (HA-FAST) 
lysates. Arrow points to the 65-kD autophosphorylated recombinant HA- 
FAST. (/3) Renaturation kinase assay prepared using immunoprecipitates 
from COS (HA-FAST) or COS (vector) lysates. Proteins separated on a 
10% SDS-polyacrylamide  gel were transferred to nitrocellulose,  and rena- 
tured before incubation with [3~-32p]ATP  in kinase buffer. Arrow points 
to the 65-kD autophoshorylated  protein precipitated from Cos (HA-FAST) 
transformants, but not COS (vector)  transformants using anti-HA but 
not an isotype-matched control mAb. (C) Phosphoamino acid analysis 
of autophosphorylated HA-FAST. PS; phosphoserine;/~, phosphothreo- 
nine; PY~ phosphotyrosine. 
(right panel), but not with 32P04 (left panel).  The mAb reac- 
tive with TIA-1 (anti-Ill10) coprecipitates a doublet centered 
at 60-kD which is labeled  with both 3sS (right panel)  and 
32p04  (left panel).  This 60-kD doublet comigrates with en- 
dogenous FAST precipitated with an mAb reactive with FAST 
(anti-2DS). The anti-FAST antibody does not coprecipitate 
TIA-1,  suggesting  that  its  epitope  may  be  part  of  the 
FAS1TFIA-l-binding  site. The ability of anti-lFI10 to precipitate 
p40-TIA-1 and p53-TIA-1 was surprising since a previously 
described mAb reactive with the carboxyl-terminus of TIA-1 
(anti-2G9)  did not precipitate the full-length RNA binding 
proteins from lysates prepared from noncytotoxic cells (34). 
Anti-ML29, an mAb reactive with a distinct amino-terminal 
TIA-1 epitope, also precipitates p40-TIA-1 and p53-TIA-1 from 
noncytotoxic cells (see  below). These results suggest that the 
carboxyl terminus of TIA-1 is not accessible to anti-2G9 in 
cell lysates, possibly because it interacts with another pro- 
tein. The detection of p40-TIA-1 protein in noncytotoxic cells 
is consistent with the expression of mRNA encoding p40- 
TIA-1 in a variety of cell types (22).  The observation that 
FAST associates with TIA-1 but not TIAR in cell lysates 
is consistent with data obtained using the two hybrid system. 
Figure 3.  Characterization of endog- 
enous FAST. (A) Jurkat cells metaboli- 
cally hbeled with 32pO4 were solubilized 
in NP-40 lysis buffer and immunoprecip- 
itated using anti-FAST,  or  an isotype- 
matched control mAb. Arrows point to 
the FAST doublet centered around 60 kD. 
(B) Phosphoamino acid analysis ofphos- 
phorylated endogenous FAST. Both the 
upper  and  lower bands  gave  a  similar 
phosphoamino acid analysis. 
TIA-1 Is a Substrate  for FAST In Vitra  The ability of FAST 
to interact with the carboxyl terminus of TIA-1 suggests that 
it may phosphorylate TIA-L We therefore tested the sub- 
strate specificity of FAST in the in vitro kinase assay shown 
in Fig.  5.  Immunoprecipitates prepared from a COS (HA- 
FAST) transformant (lanes 1-5) or a COS (vector) transfor- 
mant (lane 6) using anti-FAST (lanes I-4 and 6) or a control 
mAb (lane 5) were incubated with [3,-32p]ATP in the pres- 
ence of GST (lane 1 ), GST-fyn-SH3 (lane 2), GST-p15-TIA-1 
(lane 3), or GST-p40-TIA-1 (lanes 4-6) before electrophoretic 
separation,  nitrocellulose transfer, and autoradiography. The 
65-kD HA-FAST protein was identified in anti-FAST precipi- 
tates from COS (HA-FAST)  transformants (lanes I-4),  but 
not in control precipitates  (lanes 5 and 6). Both GST-p15- 
TIA-1 (lane 3, arrow) and GST-p40-TIA-1 (lane 4, arrowhead) 
(identified in the anti-TIA-1 immunoblot shown in the right 
panel)  were phosphorylated in the presence  of HA-FAST, 
whereas GST (lane 1 ) and GST-fyn-SH3 (lane 2) were not. 
The observation that GST-fyn-SH3  is not an efficient sub- 
strate  for FAST, in spite of the fact that it binds to FAST 
in vitro, indicates that TIA-1 may be a relatively specific sub- 
strate  for FAST. 
TIA-I  Is a Substrate  for FAST In Viw  The identification 
of p40-TIA-1 as a FAST substrate in vitro suggested that it 
might also be a physiological FAST substrate. Although TIA-1 
is not constitutively phosphorylated (our unpublished ob- 
servations), its ability to trigger DNA fragmentation in per- 
meabilized thymocytes suggests that it might play a role in 
signaling apoptosis (22). We therefore monitored the phos- 
phorylation of TIA-1 in 32pO4-1abeled Jurkat cells triggered 
869  Tian et al. Figure 4.  Interaction between TIA-1 and FAST. 
(A) In vitro. Lysates prepared from COS (HA- 
FAST) transformants were precipitated with anti- 
FAST or the indicated af~nity  ligand, (GS'E gluta- 
thione~S-transferase;  GST-p15-TIA-1:  fusion protein 
encoding the carboxyl terminus of TIA-1;  GST- 
p40-TIA-I: fusion protein encoding the full length 
TIA-1 RNA-binding protein), separated on a 10% 
SDS-polyacrylamide  gel, transferred to nitrocdh- 
lose, and probed using an mAb reactive with FAST 
(anti-2B5). Arrow points to the 65-kD HA-FAST 
protein. The relative migration of molecular size 
markers is indicated at the left. (B) In vivo. Jurkat 
cells metabolically labeled with either 32PO4 (left 
panel) or psS]methionine  (right panel) were solubi- 
lized in digitonin lysis buffer and immunoprecipi- 
tated using mAbs reactive with: TIA-1 (1H10), 
TIAR (6F.3  and 3E6), FAST (anti-2D5). The rela- 
tive migration of molecular size markers is shown 
at the left. 
to undergo apoptosis by antibodies  reactive with Fas. Im- 
munoprecipitates prepared using an mAb reactive with TIA-1 
(anti-ML29)  showed that both TIA-1 isoforms (p40-TIA-1 
and p53-TIA-1) are transiently phosphorylated (Fig. 6 A, upper 
Figure 5.  TIA-1 is a substrate for FAST in vitro. (Left) Analysis of in 
vitro kinase assays  prepared using anti-FAST immunoprecipitates from COS 
(HA-FAST) lysates (lanes 1-4 ) or from COS (vector) lysates (lane 5). Anal- 
ysis of control immunoprecipitates prepared from COS (HA-FAST) ly- 
sates are shown in lane 6. Kinase assays were performed in the presence 
of the following purified, exogenous proteins added in equimolar amounts 
(1 #M): GST (lane I ), GST-fyn-SH3  (lane 2), GST-plS-TIA-1 (lane 3), 
GST-p40-TIA-1  (lanes 4-6). The relative migration of molecular size markers 
is shown at the right. Arrow points to phosphorylated p15-TIA-1 and ar- 
rowhead points to phosphorylated p40-TIA-1 which were identified by 
immunoblotting using an mAb reactive with TIA-1 (anti-2Gg)  as shown 
in the right panel. 
panel) on serine residues (Fig. 6 B) in response to Fas liga- 
tion.  Because  immunoblotting  analysis showed  that  the 
amount of TIA-1 protein is not significantly affected by Fas 
ligation (Fig. 6 A, lower  panel), its transient phosphorylation 
is  likely  to  result  from  its  sequential  modification  by  a 
serine/threonine kinase and a serine/threonine phosphatase. 
The kinetics of DNA fragmentation induced by Fas ligation 
are shown in Fig. 6 C. In this representative  experiment, phos- 
phorylation of TIA-1 precedes the onset of DNA fragmenta- 
tion by at least 30 rain. 
Although FAST and TIA-1 form an intermolecular com- 
plex in Jurkat lysates (Fig. 4 B), TIA-1 is only phosphorylated 
after Fas ligation. This result suggests that FAST is activated 
in response to this stimulus. We therefore monitored the phos- 
phorylation of FAST and TIA-1 in Jurkat cells treated with 
anti-Fas. As shown in Fig. 7 A  (left  panel), phosphorylated 
FAST rapidly disappears from Jurkat cells triggered with anti- 
Fas. Although immunoblotting analysis was not sufficiently 
sensitive to detect the endogenous FAST protein in this ex- 
periment, parallel experiments using 3SS-labeled  Jurkat cells 
showed that the amount of FAST protein does not significantly 
change during the first 3 h of Fas-mediated apoptosis (data 
not shown). Therefore, the disappearance of phosphorylated 
FAST probably results from its specific dephosphorylation. 
Dephosphorylation of FAST is usually detected 30-60 min 
after the addition of anti-Fas, and the dephosphorylation of 
FAST coincides with the phosphorylation of TIA-1 (Fig. 7 
A, middle  panel). The specificity control in this experiment 
is an mAb reactive with TIAR, a TIA-l-related RNA-binding 
protein (23) that is not phosphorylated after Fas ligation (Fig. 
7 A, right  panel). The simplest interpretation of these results 
is that dephosphorylation activates FAST to phosphorylate 
TIA-1. This possibility is supported by the observation that 
Fas  ligation  activates the  autophosphorylation  and trans- 
phosphorylation activities of FAST in vitro (Fig.  7 B).  In 
this experiment, Jurkat cells were treated with anti-Fas for 
the indicated times, solubilized in NP-40 lysis buffer, and im- 
munoprecipitated using an mAb reactive with FAST (anti- 
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TIA-1 during Fas-mediated apop- 
toffs. (A) (UFperpanel) 32p-labeled 
Jurkat cells were treated with anti- 
Fas for the indicated times, solubi- 
lized in NP-40 lysis buffer, and im- 
munoprecipitated  using an  mAb 
reactive with TIA-1 (anti-ML29). 
After  separation  on a  10%  SDS 
polyacrylamide  gel,  and  transfer 
to nitrocellulose, 32p-labded  TIA-1 
was  revealed by autoradiography. 
The relative migration of  molecular 
size markers is shown at the right. 
(Lower  panel) The same nitroceUu- 
lose filter used to produce the auto- 
radiogram shown in the upper panel 
was subjected to immunoblotting 
analysis  using an mAb reactive  with 
TIA-1  (anti-ML29).  The  relative 
migration of molecular size markers 
is shown at  the right.  (B)  Phos- 
phoamino  acid  analysis  of  p40- 
TIA-1.  PS,  phosphoserine;  PT, 
phosphothreonine;  PY,  phos- 
photyrosine. (C) Kinetics of DNA 
fragmentation induced by Fas liga- 
tion. Jurkat cells treated with anti- 
bodies reactive with Fas in parallel 
with the experiment  shown in A 
were analyzed for DNA fragmen- 
tation as described in Materials and 
Methods. 
Figure 7.  FAST is dephosphorylated and concomitantly activated in response to Fas ligation.  (A) 32p-labded  Jurkat cells were treated with anti-Fas 
for the indicated times, solubilized in NP-40 lysis buffer, and immunoprecipitated  using mAbs reactive with FAST (anti-2D5,  left panel), TIA-1 (anti- 
ML29, middle  panel), or TIAR (anti-6E3,  rigkt panel). After separation on a 10% SDS-polyacrylamide gel, 32p-labeled  proteins were identified using 
autoradiography. The relative migration of molecular size markers is shown at the right. (B) Activation of FAST during Fas-mediated apoptosis. Jurkat 
cells (5  x  106) treated with anti-Fas for the indicated times were solubilized in NP-40 lysis buffer and immunoprecipitated  using an mAb reactive 
with FAST (anti-2D5).  Immunoprecipitates  were subjected to the in vitro kinase assay in the presence of the FAST substrate GST-p15-TIA-1  (1 #M), 
separated on a 10% SDS-polyacrylamide  gel, transfered to nitrocellulose and exposed for autoradiography. (Arrowhead)  Autophosphorylated FAST. (Arrow) 
Phosphorylated GST-p15-TIA-1  that was localized by immunoblotting  using an mAb reactive with TIA-1 (anti-2G9). The relative migration  of molecular 
size markers is shown at the right. 
871  Tian et al. 2D5). Precipitates  containing endogenous FAST were fur- 
ther incubated in kinase buffer supplemented with [~/.32p]. 
ATP, and GST-p15-TIA-1. Both autophosphoryhtion  of FAST 
(arrowhead)  and transphosphoryhtion of GST-p15-TIA-1 (arrow, 
identified by immunoblotting analysis, not shown) increased 
after Fas ligation. The kinetics of FAST activation paralleled 
the dephosphorylation of FAST and the phosphorylation of 
TIA-1  observed in  Fig.  7 A.  Phosphorylation of FAST- 
associated proteins (pp70 and pp95) was also induced by Fas 
ligation. The identity of these candidate FAST substrates is 
not known. 
To determine whether the dephosphorylation of FAST is 
specific for Fas-mediated  apoptosis, we similarly  measured 
the phosphorylation of FAST in Jurkat cells activated by an 
antibody reactive with the CD3:TCR complex. Whereas ac- 
tivation via CD3:TCR was a potent stimulus for the produc- 
tion of I1-2, we observed no change in the phosphorylation 
of FAST or TIA-1 in response to anti-CD3 (data not shown). 
These experiments were done in parallel with the experiments 
shown in Fig. 7, and included time points of 1, 2, and 3 h. 
Recent results have shown that Jurkat cells treated with anti- 
CD3 are induced to express Fas-ligand,  and that activation- 
induced death is dependent upon Fas ligation (35). Because 
this process is much slower than Fas-mediated apoptosis, it 
is still possible that anti-CD3 might induce the phosphory- 
lation of TIA-1 at later times of incubation. We were unable 
to test this possibility because of technical limitations of the 
metabolic labeling assay. Since activation via the CD3:TCR 
complex is a potent stimulus for the secretion of IL-2 in these 
cells, the observation that FAST remains phosphorylated and 
catalytically inactive at early times suggests that FAST may 
be selectively activated  during Fas-mediated  apoptosis. 
Discussion 
We have identified a serine/threonine kinase, designated 
FAST, that binds to the carboxyl terminus of the RRM-type 
RNA-binding protein TIA-1.  The deduced amino acid se- 
quence of FAST reveals a weak similarity to a serine/threo- 
nine kinase domain found at the amino terminus of the large 
subunit of herpes virus ribonucleotide reductase  (this gene 
is designated ICP6 [36] and ICP10 [29] in HSV-1 and HSV-2, 
respectively).  In HSV-2,  ICP10 is essential  for virus repli- 
cation (37), and its overexpression induces cellular transfor- 
mation. The ICP10 kinase domain is unusual in that it only 
partly conforms to the consensus motifs comprising the cata- 
lytic core of eukaryotic protein kinases (30, 38, 39).  ICP10 
is also unusual in that mutation of the invariant  lysine res- 
idue in motif II does not affect its activity (40).  Thus, al- 
though ICP10 possesses kinase activity,  its phylogenic rela- 
tionship to other known protein kinases is relatively distant. 
FAST is more closely related  to ICP10 than it is to other 
eukaryotic protein kinases.  It also lacks several "invariant" 
residues defined by kinase consensus motifs. These include 
the alanine residue in motif II, both the aspartic  acid and 
asparagine residues in motif VI, and the aspartic acid residue 
in motif VII. Because the aspartic acid residue in motif VII 
normally interacts with the asparagine residue in motif VI 
(39), the absence of both of these normally invariant amino 
acids suggests that the catalytic core of FAST may differ 
significantly from that of most protein kinases. In addition, 
there is an amino acid insertion that disrupts the spacing of 
motif I. Both FAST and ICPl0 also possess several inserts 
(labded A-F in Fig. 1 B) which could interrupt the catalytic 
core of the kinase domain. Each of these inserts is found in 
a position that could be accommodated without disrupting 
the conserved catalytic core (39), however, suggesting that 
they may contribute to substrate specificity. FAST and ICP10 
both encode a proline-rich domain that is a potential binding 
site for SH3 domains (33). ICP10 interacts with proteins con- 
taining SH3 domains (e.g.,  son-of-sevenless and Grb-2) in 
cells. FAST also interacts with proteins possessing SH3 do- 
mains in vitro (unpublished results), but the relevance of this 
property to the function of FAST is unknown. 
Our results indicate that FAST can efficiently bind and 
phosphorylate the carboxyl terminus of TIA-1 in vitro. The 
observation that FAST and TIA-1 form a complex in cell 1y- 
sates supports the possibility that FAST might also phosphory- 
late TIA-1 in vivo. We have shown that TIA-1 is rapidly phos- 
phorylated on serine residues in response to antibody-mediated 
Fas ligation. Phosphorylated TIA-1 is detected in cell lysates 
prepared between 1 and 2 h after Fas ligation. Because TIA-1 
is no longer phosphorylated in cell lysates prepared 3 h after 
Fas ligation, its phosphorylation may be regulated by a con- 
stitutively active phosphatase. This result implies that the ki- 
nase responsible for phosphorylating TIA-1 is activated within 
1 h, and inactivated within 3 h, of Fas ligation. The kinase 
activity of FAST precipitated from  Jurkat lysates is transiently 
increased after  Fas ligation, with kinetics that parallel the 
phosphorylation of TIA-1.  Because dephosphorylation of 
FAST is also observed 1 h after Fas ligation, it may be the 
target of a Fas-activated Ser/Thr phosphatase. Taken together, 
our results strongly suggest that FAST is responsible for the 
phosphorylation of TIA-1 during Fas-mediated  apoptosis. 
Fas ligation has been shown to activate sphingomyelin  hy- 
drolysis, resulting in the production of ceramide (11). Cera- 
mide, in turn, has been shown to directly trigger apoptosis 
in selected Fas-sensitive cell lines (11). Although ceramide may 
be an important component of the Fas signaling mechanism, 
it is clearly not sufficient for the induction of apoptosis, since 
ceramide is produced after ligation of a variety of receptors 
that do not trigger apoptosis (e.g., receptors for IL1B, IFN-% 
and TNF-c~) (12, 13). On the other hand, ceramide has been 
shown to activate several intracellular protein kinases (14, 15) 
and phosphatases (16). Thus, the presence or absence of specific 
kinases or phosphatases might influence a cell's susceptibility 
to Fas-mediated  apoptosis. It is possible,  for example, that 
ceramide activates the Ser/Thr protein phosphatase respon- 
sible for FAST activation. It will be important to correlate 
the expression of FAST, and its putative activating phospha- 
tase with the relative susceptibility to Fas-mediated apoptosis 
in various  cell lines. 
Our results introduce FAST and TIA-1 as components of 
a molecular cascade that is activated during Fas-mediated apop- 
872  Fas-activated  Serine/Threonine Kinase tosis. It remains to be determined whether activation of FAST 
or phosphorylation of TIA-1 is required for signaling apop- 
toffs. By determining the effect of functionally inactive FAST 
mutants on Fas-mediated apoptosis, it may be possible to an- 
swer this important  question.  It also remains  to be deter- 
mined whether p15-TIA-1  expressed in the granules of cyto- 
toxic lymphocytes can cooperate with  the Fas pathway to 
activate the FAS1TflA-1 cascade.  Because CTLs can trigger 
apoptosis via two independent mechanisms (i.e., granule exo- 
cytosis and Fas) (41-44), identifying a role for p15-TIA-1  in 
this process will require the production of CTLs which lack 
p15-TIA-1.  If TIA-1 is required for signaling apoptosis, how 
might the phosphorylation of a nudear KNA-binding pro- 
tein signal apoptotic cell death? One possibility is that TIA-1 
regulates the processing of an RNA transcript  encoding a 
regulator of apoptosis. Alternative splicing of ICE (45), Ich-1 
(46), and bcl-x (47-49) can produce mRNAs encoding both 
positive and negative regulators of apoptosis. Thus, if TIA-1 
were to regulate the splicing of a proteins such as ICE, Ich-1, 
or bd-x, its phosphorylation could result in the preferential 
selection ofisoforms that promote apoptosis. By determining 
the RNA sequence recognized by the RRM motifs of TIA-1, 
we might be able to identify a specific RNA transcript whose 
translation  is affected by TIA-1. 
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